用己烯雌酚磷酸酯和溴隐亭治疗的前列腺癌患者的五年临床随访
Five-year clinical follow-up of prostatic cancer patients treated with fosfestrol and bromocriptine.
作者信息
Jeromin L, Wiśniewski J, Rozniecki M, Janiak Z, Borkiewicz J
出版信息
Int Urol Nephrol. 1987;19(1):81-5. doi: 10.1007/BF02549682.
PMID:3583616
Abstract
A five-year follow-up is presented of 123 patients with recently diagnosed prostatic cancer, confirmed histopathologically and treated with fosfestrol and bromocriptine. The combined treatment has been shown to prevent most of the complications and side effects of therapy, thus it is considered to be worthy of recommendation.
摘要
本文对123例近期诊断为前列腺癌的患者进行了为期五年的随访。这些患者经组织病理学确诊，并接受了己烯雌酚磷酸酯和溴隐亭治疗。联合治疗已被证明可预防治疗的大多数并发症和副作用，因此被认为值得推荐。
Zotero 插件